Publications
Detailed Information
Therapeutic efficacy of ABN401, highly selective c-MET inhibitor, in NSCLC with MET-amplified AND/OR EGFR mutation
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Joo Seok | - |
| dc.contributor.author | Park, Kyeung Eui | - |
| dc.contributor.author | Kim, Yeong Mun | - |
| dc.contributor.author | Sha, Kevin | - |
| dc.contributor.author | Seo, Min Ji | - |
| dc.contributor.author | Hong, Sungyoul | - |
| dc.contributor.author | Choi, Jun Young | - |
| dc.contributor.author | Shin, Young Kee | - |
| dc.date.accessioned | 2022-09-30T06:00:04Z | - |
| dc.date.available | 2022-09-30T06:00:04Z | - |
| dc.date.created | 2022-07-25 | - |
| dc.date.issued | 2019-07 | - |
| dc.identifier.citation | Cancer Research, Vol.79 No.13 | - |
| dc.identifier.issn | 0008-5472 | - |
| dc.identifier.uri | https://hdl.handle.net/10371/185119 | - |
| dc.language | 영어 | - |
| dc.publisher | American Association for Cancer Research | - |
| dc.title | Therapeutic efficacy of ABN401, highly selective c-MET inhibitor, in NSCLC with MET-amplified AND/OR EGFR mutation | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.1158/1538-7445.AM2019-LB-105 | - |
| dc.citation.journaltitle | Cancer Research | - |
| dc.identifier.wosid | 000488129900305 | - |
| dc.citation.number | 13 | - |
| dc.citation.volume | 79 | - |
| dc.description.isOpenAccess | N | - |
| dc.contributor.affiliatedAuthor | Shin, Young Kee | - |
| dc.type.docType | Meeting Abstract | - |
| dc.description.journalClass | 1 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.